The Valley Desk

NCT07586618 · Interventional trial

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Overall registry status Recruiting

Phase 1

Conditions Acute Lymphoblastic Leukemia ALL, Lymphoblastic Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov